Please login to the form below

Not currently logged in

Merck Serono reveals fertility successes

Merck Serono has named the recipients of its second Grant for Fertility Innovation

Merck Serono has announced the recipients of its Grant for Fertility Innovation.

In its second year, 55 applications were received from 14 countries around the world. The successful projects were selected by a scientific committee of fertility experts. Each entry was evaluated according to five criteria: support to increase the chances to conceive a baby, innovation, scientific rationale, feasibility and practical utility.

The winners were announced at a ceremony held at the 27th annual meeting of the European Society of Human Reproduction and Embryology (ESHRE), in the presence of Dr Alan Trounson, president of the California Institute for Regenerative Medicine, San Francisco and Dr Dagan Wells, BRC Scientific Leadership Fellow in Reproductive Genetics at the Nuffield Department of Obstetrics & Gynaecology, University of Oxford.

The company has awarded up to €1m to five innovative research projects with the same common goal: to improve the chances for couples to conceive a baby. The Grant for Fertility Innovation programme was developed by Merck Serono to support the advancement of medical science in the field of fertility.

Details about the winners can be found at

5th July 2011


Featured jobs

Subscribe to our email news alerts


Add my company
Solaris Health

The beauty of detail: an effective, compelling medical communications campaign requires each component to be carefully planned, expertly crafted and...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...